BORTEZOMIB FOR INJECTION
Google image searchProduct monograph
Active ingredient
bortezomib (bortezomib mannitol boronic ester), 3.5 MG/VIAL
DIN: 02485257
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS
Description: SINGLE USE VIAL
Schedule: Prescription
Company: JUNO PHARMACEUTICALS CORP.
Date: 28-MAR-2023
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XG — Proteasome inhibitors (ATC, ATC/DDD)
- L01XG01 — BORTEZOMIB (ATC/DDD)
Reference brand drug: Velcade
